Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Appointed director Quarterly results Director departure Inv. presentation
|
China Biologic Products Holdings, Inc. (CBPO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/03/2017 |
8-K
| Form 8-K - Current report |
02/23/2017 |
8-K
| Form 8-K - Current report |
11/02/2016 |
8-K
| Form 8-K - Current report |
05/04/2016 |
8-K
| Form 8-K - Current report |
02/25/2016 |
8-K
| Quarterly results |
11/03/2015 |
8-K
| Quarterly results |
08/05/2015 |
8-K
| Quarterly results |
05/06/2015 |
8-K
| Quarterly results |
03/04/2015 |
8-K
| Quarterly results, Resignation/termination of a director, Appointed a new director |
11/05/2014 |
8-K
| Quarterly results |
08/05/2014 |
8-K
| Quarterly results, Resignation/termination of a director |
05/06/2014 |
8-K
| Quarterly results |
03/12/2014 |
8-K
| Quarterly results |
08/06/2013 |
8-K
| Form 8-K - Current report |
05/08/2013 |
8-K
| Form 8-K - Current report |
03/13/2013 |
8-K
| Form 8-K - Current report |
11/08/2012 |
8-K
| Quarterly results |
08/09/2012 |
8-K
| Form 8-K - Current report |
05/09/2012 |
8-K
| Quarterly results |
03/12/2012 |
8-K
| Form 8-K - Current report |
11/07/2011 |
8-K
| Form 8-K - Current report |
08/09/2011 |
8-K
| Form 8-K - Current report |
05/10/2011 |
8-K
| Form 8-K - Current report |
05/09/2011 |
8-K
| Quarterly results
Docs:
|
"China Biologic Products Reports First Quarter 2011 Results Tai'an, Shandong Province, PRC, May 9, 2011 – China Biologic Products, Inc. , one of the leading plasma-based biopharmaceutical companies in the People’ s Republic of China , today reported record sales and net income for the three months ended March 31, 2011. Financial highlights for the first quarter 2011 Total sales increased 27.2% to $34.5 million in the first quarter 2011, from $27.1 million the first quarter 2010. Gross profit increased 23.9% to $25.2 million in the first quarter 2011, from $20.3 million the first quarter 2010. Income from operations increased 9.8% to $14.5 million in the first quarter 2011, from $13.2 million the first quarter 2010. Net income attributable to China Biologic decreased 40.8% to $6.3 million in..." |
|
03/31/2011 |
8-K
| Form 8-K - Current report |
11/16/2010 |
8-K
| Form 8-K - Current report |
08/16/2010 |
8-K
| Form 8-K - Current report |
05/17/2010 |
8-K
| Form 8-K - Current report |
03/24/2010 |
8-K
| Form 8-K - Current report |
11/16/2009 |
8-K
| Form 8-K - Current report |
08/17/2009 |
8-K
| Form 8-K - Current report |
11/12/2008 |
8-K
| Form 8-K - Current report |
08/18/2008 |
8-K
| Form 8-K - Current report |
05/15/2008 |
8-K
| Form 8-K - Current report |
|
|
|